EMG
XBIT icon

ETF Managers Group’s XBiotech XBIT Stock Holding History

ETF Managers Group’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,982
Closed -$33K – 696
2022
Q3 		$33K Sell
8,982
-635
-7% -$2.99K ﹤0.01% 680
2022
Q2 		$55K Buy
9,617
+396
+4% +$2.66K ﹤0.01% 708
2022
Q1 		$81K Buy
9,221
+33
+0.4% +$331 ﹤0.01% 640
2021
Q4 		$103K Sell
9,188
-1,904
-17% -$24.8K ﹤0.01% 638
2021
Q3 		$146K Buy
11,092
+2,246
+25% +$35.8K ﹤0.01% 625
2021
Q2 		$146K Sell
8,846
-117
-1% -$1.98K ﹤0.01% 615
2021
Q1 		$152K Sell
8,963
-5,269
-37% -$98.4K ﹤0.01% 626
2020
Q4 		$227K Sell
14,232
-2,007
-12% -$37K 0.01% 570
2020
Q3 		$308K Buy
16,239
+7,854
+94% +$136K 0.01% 465
2020
Q2 		$120K Buy
+8,385
New +$118K ﹤0.01% 580

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

ETF Managers Group's XBIT Position: Q4 2022 in Review

ETF Managers Group sold out of XBiotech (XBIT) in Q4 2022, closing a stake of 8,982 shares — an estimated $33K sold.

ETF Managers Group first reported a position in XBIT in Q2 2020 and held it in 10 quarters. The position peaked at $308K in Q3 2020. 40 funds tracked by Wall St. Rank hold XBIT as of Q4 2022.

  • ETF Managers Group reported no remaining XBiotech position as of Q4 2022 after selling out during the quarter.
  • ETF Managers Group sold 8,982 XBiotech shares in Q4 2022, an estimated $33K.
  • ETF Managers Group first reported a position in XBiotech in Q2 2020 and held it in 10 quarters.
  • ETF Managers Group's XBiotech position peaked at $308K in Q3 2020.
  • 40 funds tracked by Wall St. Rank held XBiotech as of Q4 2022.

Based on ETF Managers Group's 13F filing for Q4 2022, filed 23 Mar 2023.